Compare $HCWB vs $ORGS | Chartloom

Compare

$HCWB vs $ORGS

HCW Biologics Inc · Orgenesis Inc

HCWB

HCW Biologics Inc

ORGS

Orgenesis Inc

Compare $HCWB vs $ORGS

Comparing HCW Biologics Inc and Orgenesis Inc

HCWBHCW Biologics Inc

ORGSOrgenesis Inc

HCWBHCW Biologics Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

707.0%

YTD performance

-76.2%

52W performance

-94.5%

FCF yield

-474.1%

ORGSOrgenesis Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-92.8%

YTD performance

133.3%

52W performance

-56.3%

FCF yield

-505.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

HCWB

ORGS

Detailed metrics comparison

HCWB

HCW Biologics Inc

ORGS

Orgenesis Inc

Market Cap

HCWB$3M

ORGS$3M

Enterprise Value

HCWB$8M

ORGS$20M

Price

HCWB$1.60

ORGS$0.35

P/E Ratio

HCWBN/A

ORGSN/A

P/S Ratio

HCWB0.38x

ORGS3.31x

EV/Sales

HCWB1.25x

ORGS19.39x

EV/EBITDA

HCWB0.00x

ORGS0.00x

P/B Ratio

HCWB0.51x

ORGS0.28x

P/FCF Ratio

HCWBN/A

ORGSN/A

EV/FCF

HCWB-0.69x

ORGS-1.16x

PEG Ratio

HCWBN/A

ORGSN/A

Forward P/E (NTM)

HCWBN/A

ORGSN/A

Forward P/S (NTM)

HCWBN/A

ORGSN/A

Revenue (TTM)

HCWB$7M

ORGS$1M

Revenue Growth (YoY)

HCWB707.0%

ORGS-92.8%

Forward Rev Growth

HCWB5564.5%

ORGS0.0%

Gross Margin (TTM)

HCWB95.9%

ORGS-86.3%

Operating Margin (TTM)

HCWB23.1%

ORGS0.0%

EBITDA Margin (TTM)

HCWB-82.2%

ORGS-1868.2%

Net Margin (TTM)

HCWB-318.5%

ORGS-4653.6%

FCF Margin (TTM)

HCWB-180.6%

ORGS-1675.3%

Net Income (TTM)

HCWB$-21M

ORGS$-48M

FCF (TTM)

HCWB$-12M

ORGS$-17M

EPS (TTM)

HCWB-$16.12

ORGS-$9.58

ROE (TTM)

HCWB-1932.0%

ORGS-10936.0%

ROA (TTM)

HCWB-2145.0%

ORGS-20820.0%

ROIC (TTM)

HCWB-859.0%

ORGS-5864.0%

Cash

HCWB$741K

ORGS$78K

Debt

HCWB$7M

ORGS$17M

Net Cash/Debt

HCWB$-6M

ORGS$-17M

Current Ratio (TTM)

HCWB0.06x

ORGS0.03x

Quick Ratio (TTM)

HCWB0.05x

ORGS0.03x

Debt/Equity (TTM)

HCWB0.88x

ORGS1.73x

Debt/Assets (TTM)

HCWB0.0%

ORGS0.0%

Interest Coverage (TTM)

HCWBN/A

ORGSN/A

Net Debt/EBITDA (TTM)

HCWB0.00x

ORGS0.00x

Beta

HCWB2.28

ORGS3.73

52W Performance

HCWB-94.5%

ORGS-56.3%

YTD Performance

HCWB-76.2%

ORGS133.3%

% from 52W High

HCWB-94.3%

ORGS-65.0%

% from 52W Low

HCWB6.7%

ORGS34900.0%

Asset Turnover (TTM)

HCWB0.26x

ORGS0.04x

FCF Yield (TTM)

HCWB-474.1%

ORGS-505.5%

Earnings Yield (TTM)

HCWB-836.3%

ORGS-1404.2%

Dividend Yield (TTM)

HCWBN/A

ORGSN/A

Rule of 40

HCWB526.4

ORGS-1,768.0

EV/GP/RG

HCWB0.00

ORGSN/A

Ticker research

View HCWB research View ORGS research

Metric	HCWB HCW Biologics Inc	ORGS Orgenesis Inc
Market & Valuation
Market Cap	$3M	$3M
Enterprise Value	$8M	$20M
Price	$1.60	$0.35
P/E Ratio	N/A	N/A
P/S Ratio	0.38x	3.31x
EV/Sales	1.25x	19.39x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.51x	0.28x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.69x	-1.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$7M	$1M
Revenue Growth (YoY)	707.0%	-92.8%
Forward Rev Growth	5564.5%	0.0%
Profitability
Gross Margin (TTM)	95.9%	-86.3%
Operating Margin (TTM)	23.1%	0.0%
EBITDA Margin (TTM)	-82.2%	-1868.2%
Net Margin (TTM)	-318.5%	-4653.6%
FCF Margin (TTM)	-180.6%	-1675.3%
Net Income (TTM)	$-21M	$-48M
FCF (TTM)	$-12M	$-17M
EPS (TTM)	-$16.12	-$9.58
ROE (TTM)	-1932.0%	-10936.0%
ROA (TTM)	-2145.0%	-20820.0%
ROIC (TTM)	-859.0%	-5864.0%
Financial Health
Cash	$741K	$78K
Debt	$7M	$17M
Net Cash/Debt	$-6M	$-17M
Current Ratio (TTM)	0.06x	0.03x
Quick Ratio (TTM)	0.05x	0.03x
Debt/Equity (TTM)	0.88x	1.73x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.28	3.73
52W Performance	-94.5%	-56.3%
YTD Performance	-76.2%	133.3%
% from 52W High	-94.3%	-65.0%
% from 52W Low	6.7%	34900.0%
Efficiency & Yields
Asset Turnover (TTM)	0.26x	0.04x
FCF Yield (TTM)	-474.1%	-505.5%
Earnings Yield (TTM)	-836.3%	-1404.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	526.4	-1,768.0
EV/GP/RG	0.00	N/A
Ticker research	View HCWB research	View ORGS research

Valuation

P/S Ratio

HCWB

0.38x

ORGS

3.31x

EV/FCF

ORGS

-1.16x

HCWB

-0.69x

Growth & revenue

Revenue Growth TTM

HCWB

707.0%

ORGS

-92.8%

Forward Revenue Growth

HCWB

5564.5%

ORGS

0.0%

Profitability & performance

Gross Margin

HCWB

95.9%

ORGS

-86.3%

ROE

HCWB

-1932.0%

ORGS

-10936.0%

FCF Yield %

HCWB

-474.1%

ORGS

-505.5%

52-Week Performance

ORGS

-56.3%

HCWB

-94.5%

Detailed metrics comparison

HCWB

HCW Biologics Inc

ORGS

Orgenesis Inc

Market Cap

HCWB$3M

ORGS$3M

Enterprise Value

HCWB$8M

ORGS$20M

Price

HCWB$1.60

ORGS$0.35

P/E Ratio

HCWBN/A

ORGSN/A

P/S Ratio

HCWB0.38x

ORGS3.31x

EV/Sales

HCWB1.25x

ORGS19.39x

EV/EBITDA

HCWB0.00x

ORGS0.00x

P/B Ratio

HCWB0.51x

ORGS0.28x

P/FCF Ratio

HCWBN/A

ORGSN/A

EV/FCF

HCWB-0.69x

ORGS-1.16x

PEG Ratio

HCWBN/A

ORGSN/A

Forward P/E (NTM)

HCWBN/A

ORGSN/A

Forward P/S (NTM)

HCWBN/A

ORGSN/A

Revenue (TTM)

HCWB$7M

ORGS$1M

Revenue Growth (YoY)

HCWB707.0%

ORGS-92.8%

Forward Rev Growth

HCWB5564.5%

ORGS0.0%

Gross Margin (TTM)

HCWB95.9%

ORGS-86.3%

Operating Margin (TTM)

HCWB23.1%

ORGS0.0%

EBITDA Margin (TTM)

HCWB-82.2%

ORGS-1868.2%

Net Margin (TTM)

HCWB-318.5%

ORGS-4653.6%

FCF Margin (TTM)

HCWB-180.6%

ORGS-1675.3%

Net Income (TTM)

HCWB$-21M

ORGS$-48M

FCF (TTM)

HCWB$-12M

ORGS$-17M

EPS (TTM)

HCWB-$16.12

ORGS-$9.58

ROE (TTM)

HCWB-1932.0%

ORGS-10936.0%

ROA (TTM)

HCWB-2145.0%

ORGS-20820.0%

ROIC (TTM)

HCWB-859.0%

ORGS-5864.0%

Cash

HCWB$741K

ORGS$78K

Debt

HCWB$7M

ORGS$17M

Net Cash/Debt

HCWB$-6M

ORGS$-17M

Current Ratio (TTM)

HCWB0.06x

ORGS0.03x

Quick Ratio (TTM)

HCWB0.05x

ORGS0.03x

Debt/Equity (TTM)

HCWB0.88x

ORGS1.73x

Debt/Assets (TTM)

HCWB0.0%

ORGS0.0%

Interest Coverage (TTM)

HCWBN/A

ORGSN/A

Net Debt/EBITDA (TTM)

HCWB0.00x

ORGS0.00x

Beta

HCWB2.28

ORGS3.73

52W Performance

HCWB-94.5%

ORGS-56.3%

YTD Performance

HCWB-76.2%

ORGS133.3%

% from 52W High

HCWB-94.3%

ORGS-65.0%

% from 52W Low

HCWB6.7%

ORGS34900.0%

Asset Turnover (TTM)

HCWB0.26x

ORGS0.04x

FCF Yield (TTM)

HCWB-474.1%

ORGS-505.5%

Earnings Yield (TTM)

HCWB-836.3%

ORGS-1404.2%

Dividend Yield (TTM)

HCWBN/A

ORGSN/A

Rule of 40

HCWB526.4

ORGS-1,768.0

EV/GP/RG

HCWB0.00

ORGSN/A

Ticker research

View HCWB research View ORGS research

Metric	HCWB HCW Biologics Inc	ORGS Orgenesis Inc
Market & Valuation
Market Cap	$3M	$3M
Enterprise Value	$8M	$20M
Price	$1.60	$0.35
P/E Ratio	N/A	N/A
P/S Ratio	0.38x	3.31x
EV/Sales	1.25x	19.39x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.51x	0.28x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.69x	-1.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$7M	$1M
Revenue Growth (YoY)	707.0%	-92.8%
Forward Rev Growth	5564.5%	0.0%
Profitability
Gross Margin (TTM)	95.9%	-86.3%
Operating Margin (TTM)	23.1%	0.0%
EBITDA Margin (TTM)	-82.2%	-1868.2%
Net Margin (TTM)	-318.5%	-4653.6%
FCF Margin (TTM)	-180.6%	-1675.3%
Net Income (TTM)	$-21M	$-48M
FCF (TTM)	$-12M	$-17M
EPS (TTM)	-$16.12	-$9.58
ROE (TTM)	-1932.0%	-10936.0%
ROA (TTM)	-2145.0%	-20820.0%
ROIC (TTM)	-859.0%	-5864.0%
Financial Health
Cash	$741K	$78K
Debt	$7M	$17M
Net Cash/Debt	$-6M	$-17M
Current Ratio (TTM)	0.06x	0.03x
Quick Ratio (TTM)	0.05x	0.03x
Debt/Equity (TTM)	0.88x	1.73x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.28	3.73
52W Performance	-94.5%	-56.3%
YTD Performance	-76.2%	133.3%
% from 52W High	-94.3%	-65.0%
% from 52W Low	6.7%	34900.0%
Efficiency & Yields
Asset Turnover (TTM)	0.26x	0.04x
FCF Yield (TTM)	-474.1%	-505.5%
Earnings Yield (TTM)	-836.3%	-1404.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	526.4	-1,768.0
EV/GP/RG	0.00	N/A
Ticker research	View HCWB research	View ORGS research